Arai Sachiko 新井祥子

Researcher Number	80824870
Other IDs
Affiliation (Current)	2023: 金沢大学, がん進展制御研究所, 博士研究員
Affiliation (based on the past Project Information) *help	2021: 金沢大学, がん進展制御研究所, 博士研究員 2019 – 2020: 金沢大学, がん進展制御研究所, 特任助手
Review Section/Research Field	Principal Investigator Basic Section 50010:Tumor biology-related
Keywords	Principal Investigator 中枢神経系転移 / 薬物耐性 / ALK肺がん / 薬剤耐性 / ALK肺癌 / 髄膜癌腫症

ALK肺がんの髄膜がん腫症におけるALK-TKI耐性克服治療の開発Principal Investigator
- Principal Investigator
  
  新井祥子
- Project Period (FY)
  2021 – 2022
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 50010:Tumor biology-related
- Research Institution
  Kanazawa University
Identification of resistance mechanism to ALK-TKIs in leptomeningeal carcinomatosis (LMC) model with EML4-ALK NSCLC cellsPrincipal Investigator
- Principal Investigator
  
  Arai Sachiko
- Project Period (FY)
  2019 – 2020
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 50010:Tumor biology-related
- Research Institution
  Kanazawa University

All 2020 2019

All Journal Article Presentation

[Journal Article] simertinib Overcomes Alectinib Resistance Caused by Amphiregulin in a Leptomeningeal Carcinomatosis Model of ALK-Rearranged Lung Cancer.2020
- Author(s)
  Sachiko Arai, Shinji Takeuchi, Koji Fukuda, Hirokazu Taniguchi, Akihiro Nishiyama, Azusa Tanimoto, Miyako Satouchi, Kaname Yamashita, Koshiro Ohtsubo, Shigeki Nanjo, Toru Kumagai, Ryohei Katayama, Makoto Nishio, Mei-Mei Zheng, Yi-Long Wu, Hiroshi Nishihara, Takushi Yamamoto, Mitsutoshi Nakada, Seiji Yano
- Journal Title
  
  Journal of Thoracic Oncology
  
  Volume: 15 Pages: 752-765
- DOI
  10.1016/j.jtho.2020.01.001
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09649, KAKENHI-PROJECT-19K16738, KAKENHI-PROJECT-19H03524
[Presentation] EML4-ALK肺癌の髄膜癌腫症モデルにおけるamphiregulinに起因するアレクチニブ耐性の克服2020
- Author(s)
  新井　祥子
- Organizer
  日本がん転移学会
- Data Source
  KAKENHI-PROJECT-19K16738
[Presentation] Osimertinib Overcomes Alectinib Resistance Caused by Amphiregulin in a Leptomeningeal Carcinomatosis Model of EML4-ALK Lung Cancer2019
- Author(s)
  新井　祥子
- Organizer
  World Conference on Lung Cancer
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K16738
[Presentation] EML4-ALK肺癌の髄膜癌腫症モデルにおけるamphiregulinに起因するアレクチニブ耐性の克服2019
- Author(s)
  新井　祥子
- Organizer
  日本がん転移学会
- Data Source
  KAKENHI-PROJECT-19K16738

1. TAKEUCHI Shinji

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
2. RYOUHEI Katayama

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Arai Sachiko 新井祥子

Research Projects

Research Products

Co-Researchers

ALK肺がんの髄膜がん腫症におけるALK-TKI耐性克服治療の開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Identification of resistance mechanism to ALK-TKIs in leptomeningeal carcinomatosis (LMC) model with EML4-ALK NSCLC cellsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] simertinib Overcomes Alectinib Resistance Caused by Amphiregulin in a Leptomeningeal Carcinomatosis Model of ALK-Rearranged Lung Cancer.2020

Author(s)

Journal Title

DOI

Data Source

[Presentation] EML4-ALK肺癌の髄膜癌腫症モデルにおけるamphiregulinに起因するアレクチニブ耐性の克服2020

Author(s)

Organizer

Data Source

[Presentation] Osimertinib Overcomes Alectinib Resistance Caused by Amphiregulin in a Leptomeningeal Carcinomatosis Model of EML4-ALK Lung Cancer2019

Author(s)

Organizer

Data Source

[Presentation] EML4-ALK肺癌の髄膜癌腫症モデルにおけるamphiregulinに起因するアレクチニブ耐性の克服2019

Author(s)

Organizer

Data Source

Arai Sachiko 新井 祥子

Research Projects

Research Products

Co-Researchers

ALK肺がんの髄膜がん腫症におけるALK-TKI耐性克服治療の開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Identification of resistance mechanism to ALK-TKIs in leptomeningeal carcinomatosis (LMC) model with EML4-ALK NSCLC cellsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] simertinib Overcomes Alectinib Resistance Caused by Amphiregulin in a Leptomeningeal Carcinomatosis Model of ALK-Rearranged Lung Cancer.2020

Author(s)

Journal Title

DOI

Data Source

[Presentation] EML4-ALK肺癌の髄膜癌腫症モデルにおけるamphiregulinに起因するアレクチニブ耐性の克服2020

Author(s)

Organizer

Data Source

[Presentation] Osimertinib Overcomes Alectinib Resistance Caused by Amphiregulin in a Leptomeningeal Carcinomatosis Model of EML4-ALK Lung Cancer2019

Author(s)

Organizer

Data Source

[Presentation] EML4-ALK肺癌の髄膜癌腫症モデルにおけるamphiregulinに起因するアレクチニブ耐性の克服2019

Author(s)

Organizer

Data Source

Arai Sachiko 新井祥子